At a glance
- Originator Pfizer
- Class
- Mechanism of Action Glucocorticoid receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetes mellitus
Most Recent Events
- 05 Sep 2006 Discontinued - Preclinical for Diabetes mellitus in USA (unspecified route)
- 09 Jul 2002 Preclinical trials in Diabetes mellitus in USA (unspecified route)